<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Diabetes Drug Discovery Analysis - BioMedGPS Explainer</title>
    <link rel="stylesheet" href="../assets/css/style.css">
    <link rel="stylesheet" href="../assets/css/docs.css">
    <link rel="stylesheet" href="../assets/css/report.css">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <script src="https://cdn.plot.ly/plotly-latest.min.js"></script>
</head>
<body>
    <!-- Navigation -->
    <nav class="navbar">
        <div class="nav-container">
            <div class="nav-logo">
                <i class="fas fa-dna"></i>
                <span>BioMedGPS Explainer</span>
            </div>
            <ul class="nav-menu">
                <li><a href="../index.html" class="nav-link">Home</a></li>
                <li><a href="../user-guide.html" class="nav-link">User Guide</a></li>
                <li><a href="../api.html" class="nav-link">API</a></li>
                <li><a href="../examples.html" class="nav-link">Examples</a></li>
                <li><a href="../model-usage.html" class="nav-link">Model Usage</a></li>
                <li><a href="https://github.com/open-prophetdb/biomedgps-explainer" class="nav-link" target="_blank">
                    <i class="fab fa-github"></i> GitHub
                </a></li>
            </ul>
            <div class="hamburger">
                <span class="bar"></span>
                <span class="bar"></span>
                <span class="bar"></span>
            </div>
        </div>
    </nav>

    <!-- Report Header -->
    <header class="report-header">
        <div class="container">
            <div class="report-title">
                <h1><i class="fas fa-tint"></i> Diabetes Drug Discovery Analysis</h1>
                <p>Comprehensive drug repurposing analysis using BioMedGPS Explainer</p>
            </div>
            <div class="report-meta">
                <div class="meta-item">
                    <i class="fas fa-calendar"></i>
                    <span>Generated: January 20, 2024</span>
                </div>
                <div class="meta-item">
                    <i class="fas fa-disease"></i>
                    <span>Disease: Diabetes (MONDO:0005148)</span>
                </div>
                <div class="meta-item">
                    <i class="fas fa-pills"></i>
                    <span>Drugs Analyzed: 180</span>
                </div>
            </div>
        </div>
    </header>

    <!-- Report Navigation -->
    <nav class="report-nav">
        <div class="container">
            <ul class="report-tabs">
                <li><a href="#summary" class="tab-link active">Summary</a></li>
                <li><a href="#drug-predictions" class="tab-link">Drug Predictions</a></li>
                <li><a href="#network-analysis" class="tab-link">Network Analysis</a></li>
                <li><a href="#pathway-enrichment" class="tab-link">Pathway Enrichment</a></li>
                <li><a href="#visualizations" class="tab-link">Visualizations</a></li>
                <li><a href="#conclusions" class="tab-link">Conclusions</a></li>
            </ul>
        </div>
    </nav>

    <!-- Main Content -->
    <main class="report-content">
        <div class="container">
            
            <!-- Summary Section -->
            <section id="summary" class="report-section active">
                <h2>Executive Summary</h2>
                
                <div class="summary-grid">
                    <div class="summary-card">
                        <div class="summary-icon">
                            <i class="fas fa-chart-line"></i>
                        </div>
                        <h3>Top Predictions</h3>
                        <div class="summary-value">31</div>
                        <p>High-scoring drug candidates (score > 0.7)</p>
                    </div>
                    
                    <div class="summary-card">
                        <div class="summary-icon">
                            <i class="fas fa-dna"></i>
                        </div>
                        <h3>Shared Genes</h3>
                        <div class="summary-value">28</div>
                        <p>Genes shared between drugs and diabetes</p>
                    </div>
                    
                    <div class="summary-card">
                        <div class="summary-icon">
                            <i class="fas fa-route"></i>
                        </div>
                        <h3>Enriched Pathways</h3>
                        <div class="summary-value">15</div>
                        <p>Significantly enriched biological pathways</p>
                    </div>
                    
                    <div class="summary-card">
                        <div class="summary-icon">
                            <i class="fas fa-network-wired"></i>
                        </div>
                        <h3>Network Centrality</h3>
                        <div class="summary-value">12</div>
                        <p>High-centrality drug candidates</p>
                    </div>
                </div>

                <div class="summary-text">
                    <h3>Key Findings</h3>
                    <ul>
                        <li><strong>Top Candidate:</strong> Metformin shows the highest prediction score (0.91) and is already a first-line treatment for diabetes, validating our approach.</li>
                        <li><strong>Novel Candidates:</strong> 22 drugs with scores > 0.7 are not currently used for diabetes, representing potential repurposing opportunities.</li>
                        <li><strong>Pathway Insights:</strong> The analysis identified enrichment in glucose metabolism, insulin signaling, and mitochondrial function pathways, consistent with diabetes pathophysiology.</li>
                        <li><strong>Network Analysis:</strong> Several candidates show high network centrality, suggesting they may affect multiple metabolic processes relevant to diabetes.</li>
                    </ul>
                </div>
            </section>

            <!-- Drug Predictions Section -->
            <section id="drug-predictions" class="report-section">
                <h2>Drug Predictions</h2>
                
                <div class="prediction-overview">
                    <h3>Score Distribution</h3>
                    <div id="score-distribution-chart" class="chart-container"></div>
                </div>

                <div class="top-candidates">
                    <h3>Top 10 Drug Candidates</h3>
                    <div class="candidates-table">
                        <table>
                            <thead>
                                <tr>
                                    <th>Rank</th>
                                    <th>Drug Name</th>
                                    <th>Drug ID</th>
                                    <th>Prediction Score</th>
                                    <th>Existing Use</th>
                                    <th>Shared Genes</th>
                                    <th>Network Degree</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>1</td>
                                    <td>Metformin</td>
                                    <td>CHEBI:6801</td>
                                    <td>0.91</td>
                                    <td><span class="badge approved">Approved</span></td>
                                    <td>12</td>
                                    <td>18</td>
                                </tr>
                                <tr>
                                    <td>2</td>
                                    <td>Sitagliptin</td>
                                    <td>CHEBI:9140</td>
                                    <td>0.88</td>
                                    <td><span class="badge approved">Approved</span></td>
                                    <td>8</td>
                                    <td>14</td>
                                </tr>
                                <tr>
                                    <td>3</td>
                                    <td>Pioglitazone</td>
                                    <td>CHEBI:8228</td>
                                    <td>0.86</td>
                                    <td><span class="badge approved">Approved</span></td>
                                    <td>10</td>
                                    <td>16</td>
                                </tr>
                                <tr>
                                    <td>4</td>
                                    <td>Empagliflozin</td>
                                    <td>CHEBI:83435</td>
                                    <td>0.84</td>
                                    <td><span class="badge approved">Approved</span></td>
                                    <td>7</td>
                                    <td>12</td>
                                </tr>
                                <tr>
                                    <td>5</td>
                                    <td>Dapagliflozin</td>
                                    <td>CHEBI:83436</td>
                                    <td>0.82</td>
                                    <td><span class="badge approved">Approved</span></td>
                                    <td>6</td>
                                    <td>11</td>
                                </tr>
                                <tr>
                                    <td>6</td>
                                    <td>Acarbose</td>
                                    <td>CHEBI:2901</td>
                                    <td>0.80</td>
                                    <td><span class="badge approved">Approved</span></td>
                                    <td>9</td>
                                    <td>15</td>
                                </tr>
                                <tr>
                                    <td>7</td>
                                    <td>Repaglinide</td>
                                    <td>CHEBI:8743</td>
                                    <td>0.78</td>
                                    <td><span class="badge approved">Approved</span></td>
                                    <td>5</td>
                                    <td>9</td>
                                </tr>
                                <tr>
                                    <td>8</td>
                                    <td>Nateglinide</td>
                                    <td>CHEBI:7459</td>
                                    <td>0.76</td>
                                    <td><span class="badge approved">Approved</span></td>
                                    <td>4</td>
                                    <td>8</td>
                                </tr>
                                <tr>
                                    <td>9</td>
                                    <td>Rosiglitazone</td>
                                    <td>CHEBI:50122</td>
                                    <td>0.74</td>
                                    <td><span class="badge experimental">Experimental</span></td>
                                    <td>11</td>
                                    <td>17</td>
                                </tr>
                                <tr>
                                    <td>10</td>
                                    <td>Vildagliptin</td>
                                    <td>CHEBI:9141</td>
                                    <td>0.72</td>
                                    <td><span class="badge approved">Approved</span></td>
                                    <td>6</td>
                                    <td>10</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>
            </section>

            <!-- Network Analysis Section -->
            <section id="network-analysis" class="report-section">
                <h2>Network Analysis</h2>
                
                <div class="network-overview">
                    <h3>Drug-Disease-Gene Network</h3>
                    <div id="network-chart" class="chart-container"></div>
                </div>

                <div class="centrality-analysis">
                    <h3>Network Centrality Analysis</h3>
                    <div id="centrality-chart" class="chart-container"></div>
                </div>

                <div class="network-insights">
                    <h3>Key Network Insights</h3>
                    <ul>
                        <li><strong>Hub Drugs:</strong> Metformin, Pioglitazone, and Rosiglitazone show the highest degree centrality, indicating they interact with many other biological entities.</li>
                        <li><strong>Bridge Nodes:</strong> Several drugs act as bridges between different metabolic pathways, suggesting potential for multi-target therapy.</li>
                        <li><strong>Community Structure:</strong> The network shows clear communities corresponding to different therapeutic mechanisms (insulin sensitizers, DPP-4 inhibitors, SGLT2 inhibitors, etc.).</li>
                    </ul>
                </div>
            </section>

            <!-- Pathway Enrichment Section -->
            <section id="pathway-enrichment" class="report-section">
                <h2>Pathway Enrichment Analysis</h2>
                
                <div class="pathway-overview">
                    <h3>Enriched Biological Pathways</h3>
                    <div id="pathway-chart" class="chart-container"></div>
                </div>

                <div class="pathway-table">
                    <h3>Top Enriched Pathways</h3>
                    <table>
                        <thead>
                            <tr>
                                <th>Pathway Name</th>
                                <th>Enrichment Score</th>
                                <th>P-value</th>
                                <th>Drugs Involved</th>
                                <th>Genes Involved</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Glucose metabolic process</td>
                                <td>9.23</td>
                                <td>8.5e-10</td>
                                <td>15</td>
                                <td>18</td>
                            </tr>
                            <tr>
                                <td>Insulin signaling pathway</td>
                                <td>8.67</td>
                                <td>2.1e-09</td>
                                <td>12</td>
                                <td>16</td>
                            </tr>
                            <tr>
                                <td>Mitochondrial function</td>
                                <td>7.89</td>
                                <td>5.4e-08</td>
                                <td>10</td>
                                <td>14</td>
                            </tr>
                            <tr>
                                <td>Fatty acid metabolism</td>
                                <td>7.34</td>
                                <td>1.2e-07</td>
                                <td>8</td>
                                <td>12</td>
                            </tr>
                            <tr>
                                <td>AMPK signaling</td>
                                <td>6.98</td>
                                <td>3.8e-07</td>
                                <td>7</td>
                                <td>10</td>
                            </tr>
                        </tbody>
                    </table>
                </div>
            </section>

            <!-- Visualizations Section -->
            <section id="visualizations" class="report-section">
                <h2>Interactive Visualizations</h2>
                
                <div class="viz-grid">
                    <div class="viz-card">
                        <h3>Score vs Network Degree</h3>
                        <div id="score-degree-chart" class="chart-container"></div>
                    </div>
                    
                    <div class="viz-card">
                        <h3>Shared Gene Distribution</h3>
                        <div id="gene-distribution-chart" class="chart-container"></div>
                    </div>
                    
                    <div class="viz-card">
                        <h3>Drug Similarity Heatmap</h3>
                        <div id="similarity-heatmap" class="chart-container"></div>
                    </div>
                    
                    <div class="viz-card">
                        <h3>Pathway Overlap Analysis</h3>
                        <div id="pathway-overlap-chart" class="chart-container"></div>
                    </div>
                </div>
            </section>

            <!-- Conclusions Section -->
            <section id="conclusions" class="report-section">
                <h2>Conclusions and Recommendations</h2>
                
                <div class="conclusions-content">
                    <h3>Summary of Findings</h3>
                    <p>This comprehensive analysis identified 31 high-scoring drug candidates for diabetes treatment, including both approved drugs and novel repurposing opportunities. The network analysis revealed key metabolic pathways and drug-gene interactions that provide insights into potential therapeutic mechanisms.</p>
                    
                    <h3>Top Recommendations</h3>
                    <ol>
                        <li><strong>Rosiglitazone (Score: 0.74):</strong> High network centrality and multiple shared genes make this an excellent candidate for further investigation despite previous safety concerns.</li>
                        <li><strong>Acarbose (Score: 0.80):</strong> Strong alpha-glucosidase inhibitor with extensive gene overlap suggests potential for combination therapy.</li>
                        <li><strong>Repaglinide (Score: 0.78):</strong> Rapid-acting insulin secretagogue with good safety profile and relevant pathway involvement.</li>
                    </ol>
                    
                    <h3>Next Steps</h3>
                    <ul>
                        <li>Validate top candidates in preclinical models</li>
                        <li>Conduct clinical trials for novel repurposing candidates</li>
                        <li>Investigate combination therapy approaches</li>
                        <li>Explore personalized medicine applications</li>
                    </ul>
                    
                    <h3>Methodology Validation</h3>
                    <p>The identification of known diabetes drugs (Metformin, Sitagliptin, Pioglitazone) among the top predictions validates the accuracy of our knowledge graph embedding approach and provides confidence in the novel candidates identified.</p>
                </div>
            </section>
        </div>
    </main>

    <!-- Footer -->
    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-section">
                    <h3>BioMedGPS Explainer</h3>
                    <p>Generated by BioMedGPS Explainer - Drug Discovery Toolkit</p>
                </div>
                <div class="footer-section">
                    <h4>Report Info</h4>
                    <ul>
                        <li>Analysis Date: January 20, 2024</li>
                        <li>Model: TransE_l2</li>
                        <li>Disease: Diabetes (MONDO:0005148)</li>
                    </ul>
                </div>
                <div class="footer-section">
                    <h4>Resources</h4>
                    <ul>
                        <li><a href="../index.html">Home</a></li>
                        <li><a href="../user-guide.html">User Guide</a></li>
                        <li><a href="../api.html">API Documentation</a></li>
                    </ul>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2024 BioMedGPS Explainer. All rights reserved.</p>
            </div>
        </div>
    </footer>

    <script src="../assets/js/script.js"></script>
    <script src="../assets/js/report.js"></script>
</body>
</html> 